invasive ductal carcinoma

Common Name(s)

invasive ductal carcinoma, invasive ductal carcinoma, breast cancer

Invasive ductal carcinoma (IDC) is the most common type of breast cancer. IDC begins in the milk duct of the breast and spreads through the wall of the duct into the breast tissue. These cancerous cells also have the ability to spread to other parts of the body.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "invasive ductal carcinoma" for support, advocacy or research.

Logo
Breast Cancer Connections

We support people touched by breast or ovarian cancer by providing comprehensive, personalized services in an atmosphere of warmth and compassion.

Last Updated: 22 Apr 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "invasive ductal carcinoma" for support, advocacy or research.

Logo
Breast Cancer Connections

We support people touched by breast or ovarian cancer by providing comprehensive, personalized services in an atmosphere of warmth and compassion.

http://www.bcconnections.org

Last Updated: 22 Apr 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "invasive ductal carcinoma" returned 180 free, full-text research articles on human participants. First 3 results:

[Triexponential diffusion analysis in invasive ductal carcinoma and fibroadenoma].
 

Author(s): Masayuki Nakagawa, Tosiaki Miyati, Tatsuya Hayashi, Syotaro Kanao, Masahiro Taniguchi, Kyoji Higashimura, Masakazu Toi, Kaori Togashi

Journal: Nihon Hoshasen Gijutsu Gakkai Zasshi. 2014 Mar;70(3):199-205.

 

To simultaneously obtain information on diffusion and perfusion in breast lesions by diffusion-weighted magnetic resonance imaging (DWI), we analyzed three diffusion components using a triexponential function. Eighteen subjects [10 with invasive ductal carcinoma (IDC), 8 with fibroadenoma] ...

Last Updated: 20 Mar 2014

Go To URL
A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population.
 

Author(s): Seung Taek Lim, Jong Han Yu, Heung Kyu Park, Byung In Moon, Byung Kyun Ko, Young Jin Suh

Journal:

 

To investigate the clinicopathological characteristics and the survival outcomes of invasive lobular carcinoma (ILC) patients compared to invasive ductal carcinoma (IDC) patients according to their molecular subtype.

Last Updated: 16 Apr 2014

Go To URL
An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma.
 

Author(s): Dunyong Tan, KuanHui E Chen, Changhui Deng, Peizhi Tang, Jianjun Huang, Trina Mansour, Richard A Luben, Ameae M Walker

Journal: Cancer Lett.. 2014 Apr;346(1):148-57.

 

We have identified a new variant of human Stat5a, found at higher ratios to full-length Stat5a in invasive ductal carcinoma versus contiguous normal tissue. The variant, missing exon 5, inhibits p21 and Bax production and increases cell number. After prolactin stimulation, only full-length ...

Last Updated: 5 Mar 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "invasive ductal carcinoma" returned 7 free, full-text review articles on human participants. First 3 results:

Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: a case report and review of the literature.
 

Author(s): Christopher Wei Guang Ho, Sangeeta Mantoo, Chin Hong Lim, Chow Yin Wong

Journal:

 

Primary breast lymphomas (PBLs) represent less than 1% of all breast malignancies. Intravascular large B-cell lymphoma (ILBCL) is a rare, aggressive form of extranodal lymphoma. Breast involvement has only been described in the literature once previously. ILBCL is characterized by ...

Last Updated: 9 Apr 2014

Go To URL
Progression from ductal carcinoma in situ to invasive breast cancer: revisited.
 

Author(s): Catherine F Cowell, Britta Weigelt, Rita A Sakr, Charlotte K Y Ng, James Hicks, Tari A King, Jorge S Reis-Filho

Journal: Mol Oncol. 2013 Oct;7(5):859-69.

 

Ductal carcinoma in situ (DCIS) is an intraductal neoplastic proliferation of epithelial cells that is separated from the breast stroma by an intact layer of basement membrane and myoepithelial cells. DCIS is a non-obligate precursor of invasive breast cancer, and up to 40% of these ...

Last Updated: 23 Sep 2013

Go To URL
A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer.
 

Author(s): J A Glover, C M Hughes, M M Cantwell, L J Murray

Journal: Br. J. Cancer. 2011 Jun;105(1):13-7.

 

Epidemiological studies have suggested a protective effect of cyclooxygenase (COX)-inhibiting non-steroidal anti-inflammatory drugs in breast cancer risk and disease progression. We performed a systematic review to evaluate the frequency of COX-2 expression in normal breast epithelium, ...

Last Updated: 29 Jun 2011

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
 

Status: Recruiting

Condition Summary: Ductal Carcinoma In Situ

 

Last Updated: 1 Oct 2008

Go to URL
A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
 

Status: Recruiting

Condition Summary: Ductal Carcinoma in Situ

 

Last Updated: 23 Jul 2014

Go to URL
Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
 

Status: Recruiting

Condition Summary: Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II

 

Last Updated: 22 Mar 2013

Go to URL